Steris (STE) Income from Continuing Operations (2018 - 2026)
Steris (STE) posted Income from Continuing Operations of $201.0 million for Q2 2026, down 8.76% on a QoQ basis from $220.3 million in Q1 2026, and up 12.92% year-over-year from $178.0 million in Q2 2025.
Analysis
Steris (STE) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Steris has reported Income from Continuing Operations for 9 years, with the latest figure at $201.0 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 12.92% year-over-year to $201.0 million in Q2 2026; TTM through Jun 2026 was $808.1 million, a 24.42% increase from a year earlier, with the FY2026 full-year figure at $785.1 million, up 28.39% from the prior year.
- Income from Continuing Operations was $201.0 million for Q2 2026 at Steris, down from $220.3 million in the prior quarter.
- The five-year high for Income from Continuing Operations was $220.3 million in Q1 2026, with the low at $93.6 million in Q1 2022.
- Average Income from Continuing Operations over 5 years is $155.6 million, with a median of $150.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 643.72% in 2022, then decreased 15.86% in 2024.
- Over 5 years, Income from Continuing Operations stood at $131.0 million in 2022, then grew by 13.43% to $148.6 million in 2023, then advanced by 16.62% to $173.3 million in 2024, then rose by 12.12% to $194.3 million in 2025, then rose by 3.45% to $201.0 million in 2026.
- The last three Income from Continuing Operations figures came in at $201.0 million (Q2 2026), $220.3 million (Q1 2026), and $194.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 177.98 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.59 Bn | 119.38 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.07 Bn | 109.26 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 106.00 Bn | 102.52 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.53 Bn | 45.27 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 18.31 Bn | 17.90 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.00 Mn |
| Mar 31, 2026 | 220.30 Mn |
| Dec 31, 2025 | 194.30 Mn |
| Sep 30, 2025 | 192.50 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | 146.80 Mn |
| Dec 31, 2024 | 173.30 Mn |
| Sep 30, 2024 | 151.40 Mn |
| Jun 30, 2024 | 139.90 Mn |
| Mar 31, 2024 | 153.30 Mn |
| Dec 31, 2023 | 148.60 Mn |
| Sep 30, 2023 | 120.80 Mn |
| Jun 30, 2023 | 130.58 Mn |
| Mar 31, 2023 | 182.20 Mn |
| Dec 31, 2022 | 131.01 Mn |
| Sep 30, 2022 | 123.91 Mn |
| Jun 30, 2022 | 119.09 Mn |
| Mar 31, 2022 | 93.64 Mn |
| Dec 31, 2021 | 143.09 Mn |
| Sep 30, 2021 | 69.63 Mn |